NCT06703476View on ClinicalTrials.gov

A Study of Surgical Techniques During Cystectomy

PHASE3RecruitingINTERVENTIONAL
Enrollment

530

Participants

Timeline

Start Date

November 21, 2024

Primary Completion Date

November 30, 2028

Study Completion Date

November 30, 2028

Conditions
Bladder Cancer
Interventions
PROCEDURE

Stent placement

Surgeon may choose to use a single or double J ureteral stent (6- to 8.5-fr in size) or an alternative ureteral stent of the surgeon's choice.

DRUG

Alvimopan

Patient will receive alvimopan as a fixed 12-mg dose, with the first dose administered 0.5 to 5 h before the start of surgery; administration will be continued with twice daily oral doses postoperatively until hospital discharge or a maximum of 7 days (15 in-hospital doses).

Trial Locations (7)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York

10604

RECRUITING

Memorial Sloan Kettering Westchester (Consent Only), Harrison

11553

RECRUITING

Memorial Sloan Kettering Nassau (Consent Only), Rockville Centre

11725

RECRUITING

Memorial Sloan Kettering Suffolk-Commack (Consent Only), Commack

07920

RECRUITING

Memorial Sloan Kettering at Basking Ridge (Consent Only), Basking Ridge

07748

RECRUITING

Memorial Sloan Kettering Monmouth (Consent Only), Middletown

07645

RECRUITING

Memorial Sloan Kettering Bergen (Consent Only), Montvale

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER